Literature DB >> 20130533

CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis.

Emily G Lowery1, Marina Spanos, Montserrat Navarro, Angela M Lyons, Clyde W Hodge, Todd E Thiele.   

Abstract

Recent evidence suggests that corticotropin-releasing factor (CRF) receptor (CRFR) signaling is involved in modulating binge-like ethanol consumption in C57BL/6J mice. In this report, a series of experiments were performed to further characterize the role of CRFR signaling in binge-like ethanol consumption. The role of central CRFR signaling was assessed with intracerebroventricular (i.c.v.) infusion of the nonselective CRFR antagonist, alpha-helical CRF(9-41) (0, 1, 5, 10 microg/1 microl). The contribution of central CRF type 2 receptor (CRF(2)R) signaling was assessed with i.c.v. infusion of the selective CRF(2)R agonist, urocortin (Ucn) 3 (0, 0.05, 0.1, or 0.5 microg/1 microl). The role of the hypothalamic-pituitary-adrenal (HPA) axis was assessed by pretreating mice with intraperitoneal (i.p.) injection of (1) the corticosterone synthesis inhibitor, metyrapone (0, 50, 100, 150 mg/kg) or (2) the glucocorticoid receptor antagonist, mifepristone (0, 25, 50 mg/kg), and (3) by using radioimmunoassay to determine whether binge-like ethanol intake influenced plasma corticosterone levels. Finally, we determined whether the ability of the CRF(1)R antagonist, CP-154,526 (CP; 0, 10, 15 mg/kg, i.p.), to blunt binge-like drinking required normal HPA axis signaling by comparing the effectiveness of CP in adrenalectomized (ADX) and normal mice. Results showed that i.c.v. infusion of a 1 microg dose of alpha-helical CRF(9-41) significantly attenuated binge-like ethanol consumption relative to vehicle treatment, and i.c.v. infusion of Ucn 3 dose-dependently blunted binge-like drinking. On the other hand, metyrapone nonselectively reduced both ethanol and sucrose consumption, mifepristone did not alter ethanol drinking, and binge-like drinking did not correlate with plasma corticosterone levels. Finally, i.p. injection of CP significantly attenuated binge-like ethanol intake in both ADX and normal mice. Together, these results suggest that binge-like ethanol intake in C57BL/6J mice is modulated by CRF(1)R and CRF(2)R signaling, such that blockade of CRF(1)R or activation of CRF(2)R effectively reduces excessive ethanol intake. Furthermore, normal HPA axis signaling is not necessary to achieve binge-like drinking behavior.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20130533      PMCID: PMC2927867          DOI: 10.1038/npp.2009.209

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  99 in total

1.  Regulation of neuropeptide Y and its mRNA by glucocorticoids in the rat adrenal gland.

Authors:  C Laborie; F Bernet; J P Kerckaert; E Maubert; J Lesage; J P Dupouy
Journal:  Neuroendocrinology       Date:  1995-12       Impact factor: 4.914

2.  Critical role for glucocorticoid receptors in stress- and ethanol-induced locomotor sensitization.

Authors:  A J Roberts; C N Lessov; T J Phillips
Journal:  J Pharmacol Exp Ther       Date:  1995-11       Impact factor: 4.030

3.  Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis.

Authors:  E Merlo Pich; M Lorang; M Yeganeh; F Rodriguez de Fonseca; J Raber; G F Koob; F Weiss
Journal:  J Neurosci       Date:  1995-08       Impact factor: 6.167

4.  Hepatic metabolism and distribution of mifepristone and its metabolites in rats.

Authors:  O Heikinheimo; U Pesonen; R Huupponen; M Koulu; P Lähteenmäki
Journal:  Hum Reprod       Date:  1994-06       Impact factor: 6.918

5.  Consequence of long-term exposure to corticosterone or dexamethasone on ethanol consumption in the adrenalectomized rat, and the effect of type I and type II corticosteroid receptor antagonists.

Authors:  C Fahlke; E Hård; C J Eriksson; J A Engel; S Hansen
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

6.  Metyrapone-induced suppression of corticosterone synthesis reduces ethanol consumption in high-preferring rats.

Authors:  C Fahlke; E Hård; R Thomasson; J A Engel; S Hansen
Journal:  Pharmacol Biochem Behav       Date:  1994-08       Impact factor: 3.533

7.  Behavioral, neurochemical, and immunological responses to CRF administration. Is CRF a mediator of stress?

Authors:  C Song; B Earley; B E Leonard
Journal:  Ann N Y Acad Sci       Date:  1995-12-29       Impact factor: 5.691

Review 8.  The role of corticotropin-releasing factor in the anxiogenic effects of ethanol withdrawal.

Authors:  F Menzaghi; S Rassnick; S Heinrichs; H Baldwin; E M Pich; F Weiss; G F Koob
Journal:  Ann N Y Acad Sci       Date:  1994-10-31       Impact factor: 5.691

9.  Corticotropin-releasing factor up-regulates its own receptor mRNA in the paraventricular nucleus of the hypothalamus.

Authors:  T Imaki; M Naruse; S Harada; N Chikada; J Imaki; H Onodera; H Demura; W Vale
Journal:  Brain Res Mol Brain Res       Date:  1996-05

10.  Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity.

Authors:  S C Heinrichs; F Menzaghi; E M Pich; H A Baldwin; S Rassnick; K T Britton; G F Koob
Journal:  Neuropsychopharmacology       Date:  1994-11       Impact factor: 7.853

View more
  80 in total

1.  Persistent escalation of alcohol drinking in C57BL/6J mice with intermittent access to 20% ethanol.

Authors:  Lara S Hwa; Adam Chu; Sally A Levinson; Tala M Kayyali; Joseph F DeBold; Klaus A Miczek
Journal:  Alcohol Clin Exp Res       Date:  2011-06-01       Impact factor: 3.455

Review 2.  The neurobiology of binge-like ethanol drinking: evidence from rodent models.

Authors:  Gretchen M Sprow; Todd E Thiele
Journal:  Physiol Behav       Date:  2012-01-08

Review 3.  Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse.

Authors:  George R Breese; Rajita Sinha; Markus Heilig
Journal:  Pharmacol Ther       Date:  2010-10-15       Impact factor: 12.310

4.  Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats.

Authors:  Leandro F Vendruscolo; Estelle Barbier; Joel E Schlosburg; Kaushik K Misra; Timothy W Whitfield; Marian L Logrip; Catherine Rivier; Vez Repunte-Canonigo; Eric P Zorrilla; Pietro P Sanna; Markus Heilig; George F Koob
Journal:  J Neurosci       Date:  2012-05-30       Impact factor: 6.167

5.  Endocannabinoid control of the insular-bed nucleus of the stria terminalis circuit regulates negative affective behavior associated with alcohol abstinence.

Authors:  Samuel W Centanni; Bridget D Morris; Joseph R Luchsinger; Gaurav Bedse; Tracy L Fetterly; Sachin Patel; Danny G Winder
Journal:  Neuropsychopharmacology       Date:  2018-11-02       Impact factor: 7.853

6.  Commentary: studies on binge-like ethanol drinking may help to identify the neurobiological mechanisms underlying the transition to dependence.

Authors:  Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2012-02       Impact factor: 3.455

7.  The protective effects of the melanocortin receptor (MCR) agonist, melanotan-II (MTII), against binge-like ethanol drinking are facilitated by deletion of the MC3 receptor in mice.

Authors:  J J Olney; G M Sprow; M Navarro; T E Thiele
Journal:  Neuropeptides       Date:  2013-11-15       Impact factor: 3.286

8.  Levetiracetam results in increased and decreased alcohol drinking with different access procedures in C57BL/6J mice.

Authors:  Eric W Fish; Abigail E Agoglia; Michael C Krouse; R Grant Muller; J Elliott Robinson; C J Malanga
Journal:  Behav Pharmacol       Date:  2014-02       Impact factor: 2.293

9.  Pharmacological inhibition of Receptor Protein Tyrosine Phosphatase β/ζ (PTPRZ1) modulates behavioral responses to ethanol.

Authors:  Rosalía Fernández-Calle; Marta Vicente-Rodríguez; Miryam Pastor; Esther Gramage; Bruno Di Geronimo; José María Zapico; Claire Coderch; Carmen Pérez-García; Amy W Lasek; Beatriz de Pascual-Teresa; Ana Ramos; Gonzalo Herradón
Journal:  Neuropharmacology       Date:  2018-05-09       Impact factor: 5.250

10.  A corticotropin releasing factor pathway for ethanol regulation of the ventral tegmental area in the bed nucleus of the stria terminalis.

Authors:  Yuval Silberman; Robert T Matthews; Danny G Winder
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.